Amphastar Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.04 |
Market Cap |
$982.72 M |
Shares Outstanding |
47.07 M |
Public Float |
34.04 M |
Address |
11570 6th Street Rancho Cucamonga California 91730 United States |
Employees | - |
Website | http://www.amphastar.com |
Updated | 07/08/2019 |
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. |